Obesity crisis in cancer care: Gynecologic cancer prevention, treatment, and survivorship in obese women in the United States

Gynecologic Oncology

Volumn 133, Issue 1, 2014, Pages 1-3

  Modesitt, Susan ^a   Walker, Joan ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; BEHAVIOR CHANGE; BODY MASS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER SURGERY; CANCER SURVIVOR; CANCER THERAPY; EDITORIAL; ENDOMETRIUM CANCER; ENVIRONMENTAL EXPOSURE; GYNECOLOGIC CANCER; HUMAN; OBESITY; PATIENT CARE; PRIORITY JOURNAL; WEIGHT REDUCTION;

FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; OBESITY; OVERWEIGHT; RADIOTHERAPY; SURGICAL EQUIPMENT; SURVIVAL RATE; UNITED STATES;

EID: 84897057090     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.050     Document Type: Editorial

References (15)

1. K.M. Flegal, M.D. Carroll, B.K. Kit, and C.L. Ogden Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 JAMA 307 5 2012 491 497
2. National Health Examination Survey Data Accessed via Centers of Disease Control website. http://www.cdc.gov/nchs/data/hestat/obesity-adult-09-10/ obesity-adult-09-10.htm
3. M. Henretta et al. Perceptions of obesity and cancer risk in female bariatric surgery candidates: Highlighting the need for physician action for unsuspecting obese and high risk patients Gynecol Oncol 133 1 2014 73 77
4. D.M. Lubian Lopez et al. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: Is screening necessary? Gynecol Oncol 133 1 2014 56 62
5. P.A. Argenta et al. Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery Gynecol Oncol 133 1 2014 78 82
6. K.K. Ward et al. Bariatric surgery decreases the risk of uterine malignancy Gynecol Oncol 133 1 2014 63 64
7. E. Ko et al. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: Prevalence and prognostic significance Gynecol Oncol 133 1 2014 28 32
8. C. Gonthier et al. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer Gynecol Oncol 133 1 2014 33 37
9. C.C. Gunderson et al. The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study Gynecol Oncol 133 1 2014 23 27
10. K.N. Slaughter et al. Measurement of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer Gynecol Oncol 133 1 2014 11 15
11. G. Au-Yeung et al. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS) Gynecol Oncol 133 1 2014 16 22
12. National Cancer Institute at the National Institutes of Health fact sheet on obesity and cancer risk reviewed 01/03/2012 Accessed via the National Cancer Institute website at http://www.cancer.gov/cancertopics/factsheet/Risk/obesity
13. A. Berrington de Gonzalez, P. Hartge, J.R. Cerhan, A.J. Flint, L. Hannan, and R.J. MacInnis et al. Body-mass index and mortality among 1.46 million white adults N Engl J Med 363 23 2010 2211 2219
14. Institute of Medicine's (IOM) report on the "Crisis in Cancer Care Delivery" Accessed via the IOM website http://www.iom.edu/reports/2013/ delivering-high-quality-cancer-care-charting-a-new-course-for-a-system-in- crisis.aspx
15. D.E. Cohn, M. Leitao, C. Levenback, R. Berkowitz, L. Roman, and J. Lucci et al. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative Gynecol Oncol 130 3 2013 403 406